SCHEMBL1094469

SCHEMBL1094469

O=S(=O)(Nc1ccncn1)c1ccccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 7/20 0.56
SCN5A Q14524 7/20 0.56
SCN8A Q9UQD0 7/20 0.56
PKM P14618 1/20 0.54
SLC40A1 Q9NP59 1/20 0.50
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
CCR4 P51679 1/20 0.45
EDNRA P25101 1/20 0.45
HSD17B10 Q99714 2/20 0.44
PGR P06401 1/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GAA P10253 2/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 1/20 0.44
SCN9A Q15858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16110825 0.83 ALDH1A1 (0.68) PKMSLC40A1ALDH1A1MEN1KMT2A
SCHEMBL29481996 0.82 SCN1A (0.54) SCN1ASCN5ASCN8AALDH1A1EDNRA
SCHEMBL1094422 0.82 SCN1A (0.54) SCN1ASCN5ASCN8AALDH1A1EDNRA
SCHEMBL31003503 0.82 ALDH1A1 (0.55) SCN1ASCN5ASCN8APKMSLC40A1
SCHEMBL1094173 0.78 POLB (0.55) ALDH1A1HSD17B10KDM4EHPGDSMN1; SMN2
SCHEMBL1095172 0.77 SCN5A (0.61) SCN1ASCN5ASCN8ASCN9A
Hydrochloric Acid SCHEMBL20486310 0.76 SCN5A (0.60) SCN1ASCN5ASCN8ASCN9A
SCHEMBL8147216 0.75 RORA (0.49) SCN1ASCN5ASCN8AALDH1A1MEN1
SCHEMBL7868585 0.75 SCN9A (0.52) SLC40A1ALDH1A1MEN1KMT2ARXFP1
SCHEMBL22088467 0.75 EDNRA (0.56) PKMSLC40A1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8907101-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2014-12-09 US disclosed
US-20130338111-A1 Sulfonamide Derivatives ICAGEN, INC. (US) 2013-12-19 US disclosed
US-20120149679-A1 Sulfonamide Derivatives ICAGEN, INC. 2012-06-14 US disclosed
US-8153814-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2012-04-10 US disclosed
US-20100197655-A1 SULFONAMIDE DERIVATIVES Pfizer Limited Icagen, Inc. 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197655-A1 SULFONAMIDE DERIVATIVES SULT2A1, SULT1A1, TPST2 SCN1A 23/4885SCN5A 19/4885SCN8A 32/4885
US-20130338111-A1 Sulfonamide Derivatives SULT2A1, SULT1A1, TPST2 SCN1A 23/4885SCN5A 19/4885SCN8A 32/4885
US-20120149679-A1 Sulfonamide Derivatives SULT2A1, SULT1A1, TPST2 SCN1A 23/4885SCN5A 19/4885SCN8A 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.